126 related articles for article (PubMed ID: 8457719)
1. Comparative nephrotoxicity of carboplatin and cisplatin in euvolemic and dehydrated rats.
Martinez F; Deray G; Dubois M; Beaufils H; Jacquiaud C; Bourbouze R; Benhmida M; Jaudon MC; Jacobs C
Anticancer Drugs; 1993 Feb; 4(1):85-90. PubMed ID: 8457719
[TBL] [Abstract][Full Text] [Related]
2. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.
Wolfgang GH; Dominick MA; Walsh KM; Hoeschele JD; Pegg DG
Fundam Appl Toxicol; 1994 Jan; 22(1):73-9. PubMed ID: 8125216
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of verapamil on cis-platinum and carboplatinum nephrotoxicity in dehydrated and normohydrated rats.
Haragsim L; Zima T
Biochem Int; 1992 Oct; 28(2):273-6. PubMed ID: 1360799
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
7. Chronic cisplatin nephropathy in rats.
Brillet G; Deray G; Dubois M; Beaufils H; Maksud P; Bourbouze R; Jouanneau C; Jacobs C
Nephrol Dial Transplant; 1993; 8(3):206-12. PubMed ID: 8385285
[TBL] [Abstract][Full Text] [Related]
8. Renal responses to atrial natriuretic peptide (ANP) in rats with non-oliguric acute renal failure induced by cisplatin.
Nagano N; Yagi M; Kato S; Furuya Y; Miyata S; Manabe N
J Vet Med Sci; 1995 Dec; 57(6):997-1002. PubMed ID: 8720036
[TBL] [Abstract][Full Text] [Related]
9. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
[TBL] [Abstract][Full Text] [Related]
10. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of atrial natriuretic factor on cisplatin-induced acute renal failure in the rat.
Capasso G; Anastasio P; Giordano D; Albarano L; De Santo NG
Am J Nephrol; 1987; 7(3):228-34. PubMed ID: 2957916
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
Stöhr W; Paulides M; Bielack S; Jürgens H; Koscielniak E; Rossi R; Langer T; Beck JD
Pediatr Blood Cancer; 2007 Feb; 48(2):140-7. PubMed ID: 16724313
[TBL] [Abstract][Full Text] [Related]
13. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
15. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
16. Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.
McKeage MJ; Morgan SE; Boxall FE; Murrer BA; Hard GC; Harrap KR
Br J Cancer; 1993 May; 67(5):996-1000. PubMed ID: 8494733
[TBL] [Abstract][Full Text] [Related]
17. Effects of bromocriptine on single nephron and whole-kidney function in rats.
Stier CT; Cowden EA; Allison ME
J Pharmacol Exp Ther; 1982 Feb; 220(2):366-70. PubMed ID: 7057398
[TBL] [Abstract][Full Text] [Related]
18. Prevention of cisplatin nephrotoxicity by exogenous atrial natriuretic peptide.
Deegan PM; Basinger MA; Jones MM; Hande KR
Toxicology; 1996 Jan; 106(1-3):159-66. PubMed ID: 8571387
[TBL] [Abstract][Full Text] [Related]
19. The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.
Reznik LV; Myazina EM; Shakchmatova EI; Gambaryan SP; Brovtsyn VK; Natochin YV; Jones MM
Br J Cancer; 1991 Feb; 63(2):234-6. PubMed ID: 1847647
[TBL] [Abstract][Full Text] [Related]
20. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
